Zeaxanthin, an eye health nutrient, boosted tumor-fighting T cells and slowed cancer growth in mice. Human trials are still needed.
Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. Learn more about GPCR stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback